Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?

Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?

Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease with dismal prognosis. Choosing the right treatment for each patient remains one of the major challenges. A new approach being explored is the use of ex vivo models for personalized medicine. Two-dimensional cult...

Full description

Bibliographic Details
Main Authors: Diana Lourenço, Raquel Lopes, Carolina Pestana, Ana C. Queirós, Cristina João, Emilie Arnault Carneiro
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
hematologic cancer
multiple myeloma
bone marrow microenvironment
personalized therapy
3D models
ex vivo models
Online Access:https://www.mdpi.com/1422-0067/23/21/12888

Internet

https://www.mdpi.com/1422-0067/23/21/12888

Similar Items